HUM News and Press, Humana Inc. From 11/07/22

Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $1.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $500 million of the company’s 5.75 percent senior notes, due 2028 (the &#...

Summary SA Contributor Daniel Jones talks CVS's surprisingly fantastic recent earnings. Cano Health deal - don't worry too much about the rumors. Is CVS a buy? Julie Morgan: Thanks for joining me today. I'm Julie Morgan, host of Seeking Alpha's daily flagship pod...

Health insurer Humana ( NYSE: HUM ) has inked separate accelerated share repurchase agreements with Goldman Sachs and Mizuho to buy back $1.0B worth of the company's common stock as part of a $3B stock repurchase program announced in February. Per the terms, Humana ( ...

Humana ( NYSE: HUM ) stock rose ~2% on Wednesday after Q3 results beat estimates and the company affirmed its FY22 outlook. Q3 Adjusted EPS rose +42.4% Y/Y to $6.88, beating analysts expectations by $0.60. Revenue grew +10.16% Y/Y to $22.80B. Benefi...

Humana Inc. (HUM) Q3 2022 Earnings Conference Call November 02, 2022 9:00 AM ET Company Participants Lisa Stoner – Vice President-Investor Relations Bruce Broussard – President and Chief Executive Officer Susan Diamond – Chief Financial Offic...

Humana press release ( NYSE: HUM ): Q3 Non-GAAP EPS of $6.88 beats by $0.60 . Revenue of $22.75B (+9.0% Y/Y) misses by $30M . The company updated FY2022 EPS guidance to 'approximately $23.27' on a GAAP basis; affirms recent $0.25 per share upward revision to Ad...

Reports 3Q22 earnings per diluted common share of $9.39 on a GAAP basis, Adjusted EPS of $6.88; reports YTD 2022 EPS of $22.16 on a GAAP basis, $23.58 on an Adjusted basis Updates FY 2022 EPS guidance to 'approximately $23.27' on a GAAP basis; affirms recent $0.25 per share up...

Summary Healthcare industry, especially the large-cap pharmaceutical, biotechnology, and managed healthcare stocks are doing well and outperforming the market. More stocks in THQ’s top 70 percent equity portfolio generated high positive price growth than the number of stock...

Humana ( NYSE: HUM ) is scheduled to announce Q3 earnings results on Wednesday, November 2nd, before market open. The consensus EPS Estimate is $6.27 (+29.8% Y/Y) and the consensus Revenue Estimate is $22.78B (+9.2% Y/Y). Over the last 2 years, HUM has beaten EPS est...

“Healthcare” has done well this year in an otherwise down market and it still has opportunities that are worth buying, says Gina Sanchez – Chief Market Strategist at Lido Advisors. Sanchez is bullish on Humana Inc A name that pops out to her even though it&#...